Impact of diabetes on outcomes in hypertrophic cardiomyopathy: a GRADE meta-analysis
Seyedeh-Tarlan Mirzohreh, Niloofar Deravi, Elnaz Javanshir, Mohammad Asghari Jafarabadi, Neda Roshanravan · 2026
Read Impact of diabetes on outcomes in hypertrophic cardiomyopathy: a GRADE meta-analysis by Seyedeh-Tarlan Mirzohreh, Niloofar Deravi, Elnaz Javanshir, Mohammad Asghari Jafarabadi, Neda Roshanravan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13479635.txt.
Description
Seyedeh-Tarlan Mirzohreh and colleagues present a 2026 meta-analysis of how diabetes affects people with hypertrophic cardiomyopathy, the thick-heart disease. Diabetes might worsen rhythm risk, stiffening, and heart failure in these patients, but pooled evidence was missing. Four data banks were searched to January 2025 for studies that compare patients with and without diabetes.
Eight studies with roughly 47,600 patients in all made the cut. Results were pooled as odds ratios, and heart structure from sound-wave scans as scaled gaps. Every study passed a set bias check, and the trust in the pooled proof was graded with the GRADE method. Subgroup and stress-test checks probed whether results held across settings. The pooled work tells heart doctors how much extra watchfulness diabetes should prompt in this group.
Catalog record
| CREATOR | Seyedeh-Tarlan Mirzohreh, Niloofar Deravi, Elnaz Javanshir, Mohammad Asghari Jafarabadi, Neda Roshanravan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66773 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |